Tvardi Therapeutics Inc share price logo

Tvardi Therapeutics Inc Share Price

NASDAQ: TVRD

Mid Cap

$4.01

+0.07

(+1.78%)

as on

Tvardi Therapeutics Inc Stock Performance

as on November 8, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $3.85
    $4.2
    downward going graph

    3.99%

    Downside

    4.74%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.85
    $43.65
    downward going graph

    3.99%

    Downside

    988.53%

    Upside

    downward going graph

Tvardi Therapeutics Inc share price movements today

Previous Close
$3.94
Open
$3.92
Volume
565.4K
Day's Low - High
$3.85 - $4.2
52 Week Low - High
$3.85 - $43.65

Tvardi Therapeutics Inc Historical Returns

1 Month Return
-89.93 %
3 Month Return
-83.2 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Tvardi Therapeutics Inc Stock Fundamentals & Key Indicators

Check Tvardi Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$242.3M

EPS (TTM)

-1.9

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Tvardi Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tvardi Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Tvardi Therapeutics Inc image
Tvardi Therapeutics Inc
NA$242.3MNANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$40.5B482.44%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$58.2B238.64%1420.941.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$105.6B85.89%29.3331.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$68.0B13.75%15.5132.13%

Tvardi Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Tvardi Therapeutics Inc Stock has increased by 237% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:237% versus previous 30 day period

Tvardi Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
4
3
2
0
2
1
2
-
Gross Profit
3
2
1
0
2
1
2
0
Operating Income
-28
-4
-29
-16
-6
-6
-2
-8
EBITDA
-27
-3
-28
-18
-10
-5
-2
-8
Interest Expense
-
-
1
1
1
2
2
-
Depreciation
-
0
0
0
0
-
-
0
Income Before Tax
-28
-4
-30
-20
-12
-8
-4
4
Income Tax Expense
-
-
-
-
-
0
-
-
Net Income
-28
-4
-30
-20
-12
-7
-4
4
Net Profit Margin
-576.08%
-144.84%
-1437.75%
-2019.78%
-488.11%
-527.77%
-190.97%
0.00%

Tvardi Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
135
23
41
20
7
Gross Profit
-
21
34
14
6
Operating Income
5
-89
-21
-18
-55
EBITDA
8
-86
-20
-17
-62
Interest Expense
-
-
0
-
8
Depreciation
-
-
0
0
-
Income Before Tax
7
-88
-20
-17
-71
Income Tax Expense
0
-
-
-
0
Net Income
8
-88
-20
-17
-70
Net Profit Margin
6.23%
-384.06%
-49.06%
-82.73%
-992.95%

Tvardi Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-4
-30
-20
-12
-7
-4
0
Operating Cash Flow
-5
-30
-12
-13
-4
-4
-8
Investing Cash Flow
-30
25
15
2
5
-
-20
Financing Cash Flow
36
0
0
0
-1
1
22
Change in Cash
-5
-5
2
-10
0
-3
-13

Tvardi Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-88
-20
-17
-70
Operating Cash Flow
-60
-17
-21
-60
Investing Cash Flow
-4
-22
22
48
Financing Cash Flow
46
0
0
-3
Change in Cash
-18
-39
1
-14

Insights on Tvardi Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TVRD stock has moved down by -15.3%

About Tvardi Therapeutics Inc

Tvardi Therapeutics, Inc., formerly Cara Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting (STAT3) to treat fibrosis-driven diseases with significant unmet need. STAT3 is a central mediator across critical fibrotic signaling pathways that drive uncontrolled deposition, proliferation, survival and immune suppression. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. Its product candidate, TTI-101, is in Phase 2 clinical development for the treatment of fibrosis-driven diseases, with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is an oral, small-molecule, which is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
OrganisationTvardi Therapeutics Inc
Headquarters3 Sugar Creek Center Boulevard, Sugar Land, TX, United States, 77478
CEODr. Imran Alibhai Ph.D.
E-voting on sharesClick here to vote

Key Management of Tvardi Therapeutics Inc

Name

Title

Mr. Dan Conn J.D., M.B.A.

Chief Financial Officer

Dr. John Kauh M.D.

Chief Medical Officer

Mr. David J. Tweardy M.D.

Co-Founder & Scientific Advisory Board Member

Dr. Ronald A. DePinho M.D.

Co-Founder & Chairman of Scientific Advisory Board

Dr. Michael T. Lewis Ph.D.

Co-Founder & Scientific Advisory Board Member

Mr. Stephen O'Brien CPA

VP of Finance & Corporate Controller

Dr. Yixin Chen Ph.D.

Vice President of CMC

Mr. Wallace Hall

Founder, President & Director

Dr. Jeffrey Larson DABT, Ph.D.

Senior Vice President of R&D

Dr. Imran Alibhai Ph.D.

CEO & Director

FAQs

What is Tvardi Therapeutics Inc share price today?

Tvardi Therapeutics Inc share price today is $4.01 as on at the close of the market. Tvardi Therapeutics Inc share today touched a day high of $4.2 and a low of $3.85.

What is the 52 week high and 52 week low for Tvardi Therapeutics Inc share?

Tvardi Therapeutics Inc share touched a 52 week high of $43.65 on and a 52 week low of $3.85 on . Tvardi Therapeutics Inc stock price today i.e. is closed at $4.01,which is 90.81% down from its 52 week high and 4.16% up from its 52 week low.

What is Tvardi Therapeutics Inc's market capitalisation today?

Tvardi Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Tvardi Therapeutics Inc Stock (TVRD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tvardi Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tvardi Therapeutics Inc Shares that will get you 0.3741 shares as per Tvardi Therapeutics Inc share price of $4.01 per share as on November 8, 2025 at 2:29 am IST.

What is the minimum amount required to buy Tvardi Therapeutics Inc Stock (TVRD) from India?

Indian investors can start investing in Tvardi Therapeutics Inc (TVRD) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Tvardi Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Tvardi Therapeutics Inc share’s latest price of $4.01 as on November 8, 2025 at 2:29 am IST, you will get 2.4938 shares of Tvardi Therapeutics Inc. Learn more about fractional shares .